280 related articles for article (PubMed ID: 33050920)
1. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
[TBL] [Abstract][Full Text] [Related]
2. Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
Hörner-Rieber J; Forster T; Hommertgen A; Haefner MF; Arians N; König L; Harrabi SB; Schlampp I; Weykamp F; Lischalk JW; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Hof H; Krug D; Debus J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1311-1324. PubMed ID: 33321192
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
4. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.
Forster T; Hommertgen A; Häfner MF; Arians N; König L; Harrabi SB; Schlampp I; Köhler C; Meixner E; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Golatta M; Hof H; Krug D; Debus J; Hörner-Rieber J
Radiother Oncol; 2021 Oct; 163():165-176. PubMed ID: 34480960
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial.
Askoxylakis V; Jensen AD; Häfner MF; Fetzner L; Sterzing F; Heil J; Sohn C; Hüsing J; Tiefenbacher U; Wenz F; Debus J; Hof H
BMC Cancer; 2011 Jun; 11():249. PubMed ID: 21676232
[TBL] [Abstract][Full Text] [Related]
7. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
Hardee ME; Raza S; Becker SJ; Jozsef G; Lymberis SC; Hochman T; Goldberg JD; DeWyngaert KJ; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e415-23. PubMed ID: 22019349
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03.
Choi KH; Ahn SJ; Jeong JU; Yu M; Kim JH; Jeong BK; Lee JH; Kim SH; Lee JH
Radiother Oncol; 2021 Jan; 154():179-186. PubMed ID: 32980384
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation.
Guttmann DM; Gabriel P; Kennedy C; Rate W; Grizos W; Nagda S; Wojtowicz L; Lin L; Freedman GM
Breast J; 2018 Mar; 24(2):128-132. PubMed ID: 28703444
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
Jin K; Luo J; Yu X; Guo X
Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
[TBL] [Abstract][Full Text] [Related]
15. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy.
Yang JF; Lee MS; Lin CS; Chao HL; Chen CM; Lo CH; Fan CY; Tsao CC; Huang WY
Medicine (Baltimore); 2016 Mar; 95(11):e3113. PubMed ID: 26986158
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
[TBL] [Abstract][Full Text] [Related]
18. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
Kraus-Tiefenbacher U; Sfintizky A; Welzel G; Simeonova A; Sperk E; Siebenlist K; Mai S; Wenz F
Radiat Oncol; 2012 Dec; 7():217. PubMed ID: 23249653
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]